Liver Donation after Anti-Freeze Poisoning: Safety and Implications.

被引：0
|
作者：
Sathishkumar, Subramanian [1 ]
Mcclain, Jonathan [1 ]
Uemura, Tadahiro [1 ]
Shah, Riaz [1 ]
Kadry, Zakiyah [1 ]
机构：
[1] Penn State Univ, Coll Med & Surg, Hershey, PA USA
来源：
LIVER TRANSPLANTATION | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S143 / S144
页数：2
相关论文
共 39 条
  • [31] Waitlist Outcomes for Patients Relisted Following Failed Donation After Cardiac Death Liver Transplant: Implications for Awarding Model for End-Stage Liver Disease Exception Scores
    Croome, K. P.
    Lee, D. D.
    Nguyen, J. H.
    Keaveny, A. P.
    Taner, C. B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (09) : 2420 - 2427
  • [32] Outcomes Following Donation After Circulatory Death Liver Transplantation for Hepatocellular Carcinoma and Impact of Direct-Acting Anti-Viral Therapy
    Kumar, S.
    Lin, S.
    Schold, J. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S730 - S730
  • [33] Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: A retrospective cohort study
    Chen, Guo-Dong
    Lai, Xing-Qiang
    Ko, Dicken Shiu-Chung
    Qiu, Jiang
    Wang, Chang-Xi
    Han, Ming
    Li, Jun
    Huang, Gang
    He, Xiao-Shun
    Chen, Li-Zhong
    NEPHROLOGY, 2015, 20 (08) : 539 - 543
  • [34] Efficacy, safety and pharmacokinetic profile of pasteurized intramuscular anti-hepatitis B immunoglobulin for the prophylaxis of hepatitis B virus recurrence after liver transplantation
    Filipponi, F.
    Carrai, P.
    De Simone, P.
    Franchello, A.
    Romagnoli, R.
    Salizzoni, M.
    DIGESTIVE AND LIVER DISEASE, 2007, 39 (10) : A34 - A34
  • [35] Effectiveness and Safety of Everolimus in the Treatment of Autoimmune Hepatitis Related to Anti-Hepatitis C Virus Therapy After Liver Transplant: Three Case Reports
    Casanovas, T.
    Argudo, A.
    Pena-Cala, M. C.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (06) : 2233 - 2236
  • [36] Repeated Adjuvant Anti-CEA Radioimmunotherapy After Resection of Colorectal Liver Metastases: Safety, Feasibility, and Long-Term Efficacy Results of a Prospective Phase 2 Study
    Sahlmann, Carsten-O.
    Homayounfar, Kia
    Niessner, Martin
    Dyczkowski, Jerzy
    Conradi, Lena-Christin
    Braulke, Friederike
    Meller, Birgit
    Beissbarth, Tim
    Ghadimi, Michael
    Meller, Johannes
    Goldenberg, David M.
    Liersch, Torsten
    CANCER, 2017, 123 (04) : 638 - 649
  • [37] CD36 gene is associated with intraocular pressure elevation after intravitreal application of anti-VEGF agents in patients with age-related macular degeneration: Implications for the safety of the therapy
    Matuskova, Veronika
    Balcar, Vladimir J.
    Khan, Naim A.
    Bonczek, Ondrej
    Ewerlingova, Laura
    Zeman, Tomas
    Kolar, Petr
    Vyslouzilova, Daniela
    Vlkova, Eva
    Sery, Omar
    OPHTHALMIC GENETICS, 2018, 39 (01) : 4 - 10
  • [38] Hyperimmune anti-HBS plasma for the prevention of HBV recurrence after liver transplantation: Efficacy, safety, kinetics and economics in 26 patients during 14-year experience of two centers
    Bihl, Florian K.
    Gurtner, Vanina
    Russman, Stefan
    Di Giommarino, Loriana
    Steineman, Claudia
    Cerny, Andreas
    Hadengue, Antoine
    Majno, Pietro
    Giostra, Emiliano
    Castelli, Damiano
    Mentha, Gilles
    HEPATOLOGY, 2007, 46 (04) : 472A - 472A
  • [39] Repeated anti-CEA radioimmunotherapy (RIT) with 131I-Labetuzumab after complete resection of colorectal liver metastases - safety, feasibility and long-term efficacy results of a prospective phase-II-study
    Homayounfar, K.
    Sahlmann, C.
    Niessner, M.
    Dyczkowski, J.
    Conradi, L-C.
    Braulke, F.
    Meller, B.
    Beissbarth, T.
    Ghadimi, M.
    Meller, J.
    Goldenberg, D.
    Liersch, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 13 - 13
1234